Initial blood work found hints of an infection, and the doctors initially suspected a bacterial skin infection (cellulitis) ...

The vaccine triggers strong immune responses against Mycobacterium tuberculosis and is licensed for commercial development to ...

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium ...

The number of people diagnosed with tuberculosis worldwide rose again last year, eclipsing 2023's record total.

Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS) along with the ...

A team of United States-based scientists recently conducted a study to evaluate the effect of Mycobacterium tuberculosis infection on the pathogenesis of severe acute respiratory syndrome coronavirus ...

We report a case of infective endocarditis along with severe aortic regurgitation found to have Tuberculosis on histopathology of the vegetations. To the best of our knowledge this is the first report ...

Bhubaneswar and Institute of Life Sciences (ILS) along with National Research Development Corporation (NRDC) o ...

The Global TB Report 2025 released by the World Health Organization (WHO) highlights that India’s TB incidence has reduced ...

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

The Indian Institute of Technology and the Institute of Life Sciences, in partnership with TechInvention Lifecare and the National Research Development Corporation, are advancing a novel TB vaccine.